SEDDS of gliclazide: Preparation and characterization by in-vitro, ex-vivo and in-vivo techniques

Saudi Pharmaceutical Journal

Volumn 22, Issue 4, 2014, Pages 343-348

  Nipun, Tanzina Sharmin ^a   Ashraful Islam, S M ^a  

^a UNIVERSITY OF ASIA PACIFIC   (Bangladesh)

Author keywords

Dissolution; Gliclazide; Particle size analysis; Solubility analysis; Transcutol HP; Tween 80

Indexed keywords

DIETHYLENE GLYCOL MONOETHYL ETHER; EXCIPIENT; GLICLAZIDE; GLUCOSE; OIL; POLYSORBATE 80; SURFACTANT;

ANIMAL TISSUE; ARTICLE; CHICKEN; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; INTESTINE; LASER DIFFRACTION; MOUSE; NONHUMAN; PERFORMANCE; PERMEABILITY; SELF EMULSIFYING DRUG DELIVERY SYSTEM; TECHNOLOGY;

EID: 84906237541     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2013.06.001     Document Type: Article

References (21)

1. Ashok R., Pradeep R.V. Preparation and in vivo evaluation of SMEDDS (Self-Microemulsifying Drug Delivery System) containing fenofibrate. AAPS PharmSciTech 2007, 9:44-52.
2. Atef E., Albert A. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Eur. J. Pharm. Sci. 2008, 35:257-263.
3. Aungst B.J. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 1993, 82:979-987.
4. Bala M., Priya V., Murthy T.E.G.K. Development of discriminative dissolution media for marketed gliclazide modified-release tablets. Dissolution Technol. 2012, 19(2):38-42.
5. Dias R., Sakhare S., Mali K. In-vitro absorption studies of mucoadhesive tablets of acyclovir. Indian J. Pharm. Educ. Res. 2010, 44(2):183-188.
6. Etuk E.U. Animals models for studying diabetes mellitus. Agric. Biol. J. N. Am. 2010, 1(2):130-134.
7. Ferrec E., Christophe C., Artussen P., Brayden D., Fabre G., Gires P., Grillon F., Reuset M., Rubas W., Scarino M. In vitro models of the intestinal barriers. ATLA 1999, 29:649.
8. Ginski M.G., Polli J.E. Prediction of dissolution-absorption relationship from a dissolution/Caco-2 system. Int. J. Pharm. 1999, 177:117.
9. Harrower A.D.m. Comparison of efficacy, secondary failure rate and complications of sulfonylurea. J. Diabetes Complications 1994, 8:201-203.
10. Irvine J.D., Takahashi L., Lockhart K., Cheong J., Tolan J.W., Selick H.E., Grove J.R. MDCK cells: a tool for membrane permeability screening. J. Pharm. Sci. 1999, 88:28.
11. Kale V., Kasliwal R.H., Avari J.G. Attempt to design continuous dissolution-absorption system using everted intestine segment for in vitro absorption studies of slow drug release formulations. Dissolution Tech. 2007, 5:31-36.
12. Kim H.J., Yoon K.A., Hahn M., Park E.S., Chi S.C. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev. Ind. Pharm. 2000, 26:523-529.
13. Kommuru T.R., Gurley B., Khan M.A., Reddy I.K. Self-emulsifyingdrug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 2001, 212:233-246.
14. Kumar A., Sharma S., Kamble R. Self-emulsifyingdrug delivery system (SEDDS): future aspects. Int. J. Pharm. Pharm. Sci. 2010, 2:7-13.
15. Oishi T.S., Nimmi I., Islam S.M.A. Comparative in vitro bioequivalence analysis of some generic tablets of atorvastatin. A BCS Class II compound. BPJ 2011, 14(1):61-66.
16. Palmer K.J., Brogden R.N. Gliclazide, an update of its pharmacological properties and therapeutic efficacy in NIDDM. Drugs 1993, 46:92-125.
17. Patil P., Patil V., Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: in vitro and in vivo evaluation. Acta Pharm. 2007, 57:111-122.
18. Pouton C.W. Lipid formulations for oral administration of drugs: non- emulsifying, self emulsifying and self micro-emulsifying drug delivery system. Eur. J. Pharm. Sci. 2000, 11:93-98.
19. Shah N.H., Carvajal M.T., Patel C.I., Infeld M.H., Malick A.W. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 1994, 106:15-23.
20. Srivastav M., Prabhakar B., Omray A. Effect of alkaline excipients on the release profile of gliclazide extended release tablets. J. Pharm. Sci. Technol. 2011, 3(1):462-469.
21. Tukker J.J. In vitro methods for the assessment of permeability. Oral Drug Absorption 2000, 51. Marcel Dekker, New York. J.B. Dressman, H. Lennernas (Eds.).